Evidence map›Paper›PMID 36153563›Full record

ArticleStem cell research & therapy2022

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation.

Ying Yang, Ming Zhang, Mengqi Li, Yingchun Li, Wei Yang, Zhuogang Liu, Hongtao Wang

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying YangShengjing Hospital of China Medical University, Shenyang, China.
Ming ZhangShengjing Hospital of China Medical University, Shenyang, China.
Mengqi LiShengjing Hospital of China Medical University, Shenyang, China.
Yingchun LiShengjing Hospital of China Medical University, Shenyang, China.
Wei YangShengjing Hospital of China Medical University, Shenyang, China.
Zhuogang LiuShengjing Hospital of China Medical University, Shenyang, China.
Hongtao WangShengjing Hospital of China Medical University, Shenyang, China. wanght@sj-hospital.org.ORCID 0000-0002-6095-7774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHaploidentical hematopoietic stem cell transplantation (haplo-HSCT) is widely used as a curative treatment strategy for most types of hematological diseases. However, strategies for enhancing the graft versus leukemia (GVL) effect without aggravating the graft versus host disease (GVHD) effect are still being pursued.

methodsA retrospective cohort study was performed to compare the outcomes between combined unrelated umbilical cord blood (UCB-haplo HSCT) and haplo HSCT.

resultsThe results showed that neither acute GVHD (aGVHD) nor chronic GVHD (cGVHD) was increased in the UCB-haplo HSCT group, and the engraftment and infection rates were similar between the two groups. However, overall survival and progression-free survival were significantly improved, while transplantation-related mortality and relapse were significantly decreased in the UCB-haplo HSCT group by both univariate and multivariate analyses.

conclusionOur results indicated that the addition of a UCB unit could improve the prognosis of haplo-HSCT and enhance the GVL effect without increasing the incidence of GVHD.

trial registrationThe cohort study was retrospectively registered at https://www.chictr.org.cn as ChiCTR2100046681.

Indexed as

Cord Blood Stem Cell TransplantationGraft vs Host DiseaseHematopoietic Stem Cell TransplantationCohort StudiesFetal BloodHumansRetrospective StudiesTransplantation ConditioningGraft versus host diseaseGraft versus leukemiaHaploidentical hematopoietic stem cell transplantationPrognosisUnrelated umbilical cord blood

Identifiers

PMID36153563
PMCPMC9509542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.